IPSS-M risk categories and clinical outcomesa
| Risk category . | Median leukemia-free survival, y . | Median overall survival, y . | AML transformation by 1 year, % . |
|---|---|---|---|
| Very low (14% of all patients) | 9.7 | 10.6 | 0 |
| Low (32%) | 5.9 | 6.0 | 1.7 |
| Moderately low (11%) | 4.5 | 4.6 | 4.9 |
| Moderately high (11%) | 2.3 | 2.8 | 9.5 |
| High (14%) | 1.5 | 1.7 | 14.3 |
| Very high (18%) | 0.7 | 1.0 | 28.2 |
| Risk category . | Median leukemia-free survival, y . | Median overall survival, y . | AML transformation by 1 year, % . |
|---|---|---|---|
| Very low (14% of all patients) | 9.7 | 10.6 | 0 |
| Low (32%) | 5.9 | 6.0 | 1.7 |
| Moderately low (11%) | 4.5 | 4.6 | 4.9 |
| Moderately high (11%) | 2.3 | 2.8 | 9.5 |
| High (14%) | 1.5 | 1.7 | 14.3 |
| Very high (18%) | 0.7 | 1.0 | 28.2 |
Information is from Bernard et al.29